Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05875363
Other study ID # 202103130RIND
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2021
Est. completion date October 25, 2021

Study information

Verified date March 2023
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

1. Describe the prevalence of neurodevelopmental disorders among youth with criminal behaviors 2. Explore the relationship between specific neurodevelopmental disorders and the rates and types of crime 3. Examine the roles of psychiatric comorbidities and sociodemographic factors in juvenile criminality


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date October 25, 2021
Est. primary completion date July 31, 2021
Accepts healthy volunteers No
Gender All
Age group 10 Years to 18 Years
Eligibility Inclusion Criteria: - Juvenile offender from The Juvenile Affairs Division of Taipei City Police Department Exclusion Criteria: - Not Juvenile offender

Study Design


Intervention

Other:
collect data
The Juvenile Affairs Division provided the records without person-identifiable data (i.e., name, ID) to the researchers. The researchers coded the above data (i.e., the offenders' sociodemographic data, medical history, and criminal history). Demographic characteristics were collected, which are the offenders' age, gender, occupation, education level, and residence (district). We recorded the offenders' household members (without the name or age), main caregivers (e.g., father, or mother), and the parents' socioeconomic and marital status. We also tracked whether the offenders live with family members with mental illness, whether they are from at-risk families, and whether had been victims of domestic violence. The medical history and deviant (or criminal) behaviors will be collected in the attached measure.

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

References & Publications (14)

Ahonen L, Loeber R, Brent DA. The Association Between Serious Mental Health Problems and Violence: Some Common Assumptions and Misconceptions. Trauma Violence Abuse. 2019 Dec;20(5):613-625. doi: 10.1177/1524838017726423. Epub 2017 Aug 23. — View Citation

Coker KL, Smith PH, Westphal A, Zonana HV, McKee SA. Crime and psychiatric disorders among youth in the US population: an analysis of the National Comorbidity Survey-Adolescent Supplement. J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):888-98, 898.e1-2. doi: 10.1016/j.jaac.2014.05.007. Epub 2014 Jun 12. — View Citation

Costello EJ, Maughan B. Annual research review: Optimal outcomes of child and adolescent mental illness. J Child Psychol Psychiatry. 2015 Mar;56(3):324-41. doi: 10.1111/jcpp.12371. Epub 2014 Dec 12. — View Citation

Davison S, Janca A. Personality disorder and criminal behaviour: what is the nature of the relationship? Curr Opin Psychiatry. 2012 Jan;25(1):39-45. doi: 10.1097/YCO.0b013e32834d18f0. — View Citation

Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2009 Feb;66(2):152-61. doi: 10.1001/archgenpsychiatry.2008.537. — View Citation

Fazel S, Hayes AJ, Bartellas K, Clerici M, Trestman R. Mental health of prisoners: prevalence, adverse outcomes, and interventions. Lancet Psychiatry. 2016 Sep;3(9):871-81. doi: 10.1016/S2215-0366(16)30142-0. Epub 2016 Jul 14. — View Citation

Fischer SN, Shinn M, Shrout P, Tsemberis S. Homelessness, mental illness, and criminal activity: examining patterns over time. Am J Community Psychol. 2008 Dec;42(3-4):251-65. doi: 10.1007/s10464-008-9210-z. — View Citation

Kalvin CB, Bierman KL. Child and adolescent risk factors that differentially predict violent versus nonviolent crime. Aggress Behav. 2017 Nov;43(6):568-577. doi: 10.1002/ab.21715. Epub 2017 Jun 8. — View Citation

Lamberti JS, Katsetos V, Jacobowitz DB, Weisman RL. Psychosis, Mania and Criminal Recidivism: Associations and Implications for Prevention. Harv Rev Psychiatry. 2020 May/Jun;28(3):179-202. doi: 10.1097/HRP.0000000000000251. — View Citation

Moffitt TE. Adolescence-limited and life-course-persistent antisocial behavior: a developmental taxonomy. Psychol Rev. 1993 Oct;100(4):674-701. — View Citation

Moore KE, Oberleitner LMS, Zonana HV, Buchanan AW, Pittman BP, Verplaetse TL, Angarita GA, Roberts W, McKee SA. Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III. J Clin Psychiatry. 2019 Feb 12;80(2):18m12317. doi: 10.4088/JCP.18m12317. — View Citation

Mundt AP, Baranyi G. The Unhappy Mental Health Triad: Comorbid Severe Mental Illnesses, Personality Disorders, and Substance Use Disorders in Prison Populations. Front Psychiatry. 2020 Aug 14;11:804. doi: 10.3389/fpsyt.2020.00804. eCollection 2020. — View Citation

Skjaervo I, Skurtveit S, Clausen T, Bukten A. Substance use pattern, self-control and social network are associated with crime in a substance-using population. Drug Alcohol Rev. 2017 Mar;36(2):245-252. doi: 10.1111/dar.12406. Epub 2016 May 4. — View Citation

Swanson JW, Holzer CE 3rd, Ganju VK, Jono RT. Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys. Hosp Community Psychiatry. 1990 Jul;41(7):761-70. doi: 10.1176/ps.41.7.761. Erratum In: Hosp Community Psychiatry 1991 Sep;42(9):954-5. — View Citation

* Note: There are 14 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of ADHD, ASD, and other neurodevelopmental disorder in juvenile offender Statistical analysis done by SAS (v.9.4) examine the prevalence of each neurodelopmental disorder, such as ADHD and ASD. 3 years
Primary Age of first criminal behavior Based on different neurodevelopmental disorder diagnosis, determine whether the data is able to predict onset and type of criminal behaviors for each juvenile offender. 3 years
See also
  Status Clinical Trial Phase
Completed NCT00202605 - Safety and Efficacy of SPD465 in Adults With ADHD Phase 2
Not yet recruiting NCT02677519 - A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD Phase 4
Completed NCT02730572 - Concerta (Methylphenidate) -To-Generic Switch Study N/A
Completed NCT01681082 - Psychological Effects of Tai Chi Training N/A
Active, not recruiting NCT01330693 - Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy Phase 3
Completed NCT00830700 - Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study N/A
Completed NCT00626236 - Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems Phase 2
Completed NCT01012622 - An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) Phase 4
Completed NCT00598182 - Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study N/A
Completed NCT00381407 - Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00178503 - Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children Phase 2/Phase 3
Completed NCT00247572 - Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories Phase 2
Completed NCT00118911 - Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder N/A
Completed NCT00218322 - Effectiveness of ATMX in Treating Adolescents With ADHD and SUD Phase 4
Completed NCT00557011 - NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD Phase 2
Completed NCT00071656 - Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I N/A
Active, not recruiting NCT00057668 - Preventing Behavior Problems in Children With ADHD Phase 2
Completed NCT00050050 - Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder Phase 1
Completed NCT00050622 - Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT00031395 - Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children Phase 3